Queen's University

queensu.ca

Total trials

334

Active

39

Phase 3

20

Total enrollment

102,980

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 12 of 12 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
L-methylfolate1
Vaginal Estrogen - Twice Weekly1
Vaginal Estrogen - Daily1
Psilocybin1
Gemcitabine + BCG1
BCG1
Caffeine1
Ketamine3
Genetic testing for inherited bleeding disorders1
Vaccination Provision1
Vaccination Provision 21
Allergenic Extract Standardized Cat Hair Acetone-Precipitated1

Next readouts

  • 2026-01
  • 2026-01-08
  • 2026-04-01
  • 2026-06-01
  • 2026-12-31
  • 2027-07-31
  • 2027-09-30
  • 2028-03-31
  • 2029-09

Top conditions

  • Depression13
  • Obesity8
  • Healthy7
  • Chronic Obstructive Pulmonary Disease7
  • Physical Activity7
  • Dementia6
  • Asthma6
  • Hypertension6

Frequently asked questions about Queen's University

How many clinical trials does Queen's University have on ClinicalTrials.gov?
Queen's University is listed as the lead sponsor on 334 clinical trials in ClinicalTrials.gov, 39 of which are currently active (recruiting, enrolling, or ongoing).
How many of Queen's University's trials are in Phase 3?
20 of Queen's University's trials are in Phase 3, spread across 12 active drug programs.
What therapeutic areas does Queen's University focus on?
Queen's University's most-studied conditions on ClinicalTrials.gov are Depression, Obesity, Healthy, Chronic Obstructive Pulmonary Disease, Physical Activity.
When are Queen's University's next clinical trial readouts?
Queen's University has 9 upcoming primary-completion readouts tracked here; the soonest is “Supporting the National Expansion of HPV-based Cervical Cancer Screening in Tanzania Among Women Living with HIV”, expected around 2026-01.